- Home
- IBM vs MRK Comparison
IBM vs MRK Comparison
Compare IBM & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBM
- MRK
- Stock Information
- Founded
- IBM 1911
- MRK 2000
- Country
- IBM United States
- MRK United States
- Employees
- IBM N/A
- MRK N/A
- Industry
- IBM Computer Manufacturing
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- IBM Technology
- MRK Health Care
- Exchange
- IBM Nasdaq
- MRK Nasdaq
- Market Cap
- IBM 249.5B
- MRK 218.2B
- IPO Year
- IBM N/A
- MRK N/A
- Fundamental
- Price
- IBM $258.80
- MRK $76.82
- Analyst Decision
- IBM Buy
- MRK Buy
- Analyst Count
- IBM 14
- MRK 15
- Target Price
- IBM $254.86
- MRK $113.71
- AVG Volume (30 Days)
- IBM 3.7M
- MRK 14.7M
- Earning Date
- IBM 07-23-2025
- MRK 04-24-2025
- Dividend Yield
- IBM 2.59%
- MRK 4.22%
- EPS Growth
- IBM N/A
- MRK 667.14
- EPS
- IBM 5.83
- MRK 6.88
- Revenue
- IBM $62,832,000,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- IBM $6.42
- MRK $2.42
- Revenue Next Year
- IBM $4.34
- MRK $5.64
- P/E Ratio
- IBM $44.30
- MRK $11.17
- Revenue Growth
- IBM 1.23
- MRK 4.10
- 52 Week Low
- IBM $163.53
- MRK $73.31
- 52 Week High
- IBM $269.28
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- IBM 54.86
- MRK 44.17
- Support Level
- IBM $256.77
- MRK $75.59
- Resistance Level
- IBM $265.00
- MRK $78.20
- Average True Range (ATR)
- IBM 4.95
- MRK 2.03
- MACD
- IBM -0.67
- MRK 0.21
- Stochastic Oscillator
- IBM 57.45
- MRK 44.10
About IBM International Business Machines Corporation
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which include 95% of all Fortune 500 companies. Primary products include its mainframes, Red Hat software, transaction processing software, and IT consulting.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.